Anticoagulants Market

Anticoagulants Market - Global Market Share, Trends, Analysis and Forecasts, 2023 - 2032
Frequently asked questions about this report

Strong prevalence and growth in number of patients suffering from cardiovascular diseases, increasing number of hip and knee replacement surgical procedures, growth in atrial fibrillation, and increasing incidences of deep vein thrombosis (DVT) are the key factors fueling growth of the global anticoagulant market.

North America contributed the largest share to the global anticoagulants market and is anticipated to be a dominating geography during the forecast period owing to strong prevalence of cardiovascular disorders and increasing number of patients suffering from pulmonary embolism (PE).

Major participants in the anticoagulants industry comprise Aspen Holdings, Bayer AG, Boehringer Ingelheim GmbH, Bristol-Myers Squibb Company, Daiichi Sankyo Company, Limited, GlaxoSmithKline plc., Janssen Pharmaceuticals, Inc. (A Johnson & Johnson company), Pfizer, Inc., Portola Pharmaceuticals, Inc., and Sanofi S.A.

Based on drug class, the anticoagulants market is segmented into novel oral anticoagulants (NOACs), heparin & low-molecular-weight heparin (LMWH), vitamin K antagonist, and others.